Independent. No paid placement. Reviewed weekly Editorial policy Newsletter

HomeThe LibraryAre peptides legal?

Are peptides legal?

It depends entirely on which peptide, in what form, and where you are. Topical cosmetic peptides are straightforwardly legal. Injectable research-labelled peptides sold for human use generally are not — whatever the label says.

In brief

Should you care? Yes, before you buy anything — this is the single most consequential question in the category and the one most searched-for pages answer badly. “Peptides” covers everything from a face serum to an unapproved injectable drug, and the legal answer is completely different for each.

The short version

  • Topical cosmetic peptides: lawful, sold openly, appearance claims only.
  • Prescription peptide medicines: legal with a valid prescription from a licensed pharmacy.
  • “Research use only” injectable peptides sold to consumers: generally unapproved drugs, regardless of the label.

There is no single answer

"Are peptides legal" is really three or four different questions wearing one word. A copper peptide serum, a prescription GLP-1 injection, and a vial of "research use only" BPC-157 are all "peptides," and each sits in a completely different legal category. Anyone answering this question in one sentence is skipping the part that actually matters to you.

The three categories that actually matter

Legal status by category, not by the word "peptide"
CategoryStatusExample
Topical cosmetic peptidesLawful, openly sold, appearance claims onlyCopper peptide, Matrixyl, Argireline
Approved prescription peptide medicinesLegal with a valid prescription, dispensed by a licensed pharmacySemaglutide, tirzepatide, bremelanotide (branded)
"Research use only" peptides marketed to consumersGenerally unapproved drugs when sold for human use, whatever the label saysBPC-157, TB-500, most grey-market injectables

Why "research use only" doesn’t settle it

US regulators treat a product’s intended use, not its label, as the deciding factor. If a website sells a peptide with dosing guidance, testimonials, or any description of a human effect, regulators can treat that as evidence the product is intended for human use — regardless of a "not for human consumption" disclaimer on the vial. This has been the basis for a string of enforcement actions and, in at least one prominent case, criminal sentencing of vendors. The tracker covers the specific enforcement timeline in detail.

Country matters too

Legal status isn’t only a US question. The same compound can be prescription-only in the UK, outright prohibited in Australia, and sit in a grey area in the EU depending on the member state. If you’re outside the US, treat every figure on this site as a US-centric starting point, not a global answer — check your own country’s regulator before assuming a US legal status carries over.

Where to check a specific compound

This page explains the categories; the legal status tracker tracks the actual, current position of specific compounds as it changes — including the distinction between a substance being removed from a restricted list and it becoming lawful, which is not the same thing and is explained in detail there.

References

  1. 21 CFR 201.128, "Meaning of 'intended uses'" (amended effective 1 September 2021, 86 Fed. Reg. 41383) — intent is drawn from the totality of the evidence (labelling, advertising, circumstances of sale), not a disclaimer alone. ecfr.gov, 21 CFR 201.128. FDA has applied the same "research use only" principle by name to a different product class in its 2013 guidance on in vitro diagnostics, stating plainly that an RUO label "does not render the device exempt from otherwise applicable requirements."
  2. Country-specific regulatory summaries (US, UK, EU, Australia) as tracked on the legal status tracker.